ALK Inhibition in Two Emblematic Cases of Pediatric Inflammatory Myofibroblastic Tumor: Efficacy and Side Effects

Pediatric Blood and Cancer - United States
doi 10.1002/pbc.27645
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

P2.17-001 Pulmonary Inflammatory Myofibroblastic Tumor With TPM4-ALK Translocation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Inflammatory Myofibroblastic Tumor of the Spermatic Cord: Two Cases and Review of the Literature

Annals of Saudi Medicine
Medicine
2020English

TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors

American Journal of Pathology
Forensic MedicinePathology
2000English

Maxillary Inflammatory Myofibroblastic Tumor

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2016English

Inflammatory Myofibroblastic Tumor of the Breast

Case Reports in Surgery
2015English

Drastic Initial Response and Subsequent Response to Two ALK Inhibitors in a Patient With a Highly Aggressive ALK-rearranged Inflammatory Myofibroblastic Tumor Arising in the Pleural Cavity

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2016English

Soft Tissue Tumors: Inflammatory Myofibroblastic Tumor

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Inflammatory Myofibroblastic Tumor of Common Bile Duct

Khirurgiya
MedicineSurgery
2018English

Inflammatory Myofibroblastic Tumor: A Rare Tumor in the Tongue

Case Reports in Otolaryngology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy